Ben is Chief Technology Officer at Engage Bio. He obtained his PhD at MRC Toxicology Unit in Cambridge, where he focused on understanding the role of RNA in DNA repair mechanisms. Ben later moved to Weill Cornell where he completed a postdoc studying RNA modifications.

Will is the Co-Founder and CEO of Engage Bio. He was previously VP of mRNA Therapeutic Development at Stanford spinout Rejuvenation Technologies, and prior to that co-founded the diagnostic startup Luminist Labs in 2015 (acquired in 2019, now owned by Viome).